Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W McCarthy

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Expert Opinion on Pharmacotherapy|March 17, 2023
Montelukast as a potential treatment for COVID-19Matthew W McCarthy
Drugs of Today (Barcelona, Spain : 1998)|February 27, 2023
Anakinra as a potential treatment for COVID-19Matthew W McCarthy
Expert Opinion on Drug Metabolism & Toxicology|March 3, 2025
Ceftobiprole medocaril for skin and skin-structure infectionsMatthew W McCarthy
Expert Opinion on Pharmacotherapy|February 23, 2024
Simnotrelvir as a potential treatment for COVID-19Matthew W McCarthy
Expert Opinion on Pharmacotherapy|September 21, 2024
The first five years of SARS-CoV-2: inpatient treatment updates and future directionsMatthew W McCarthy
Expert Opinion on Biological Therapy|July 8, 2023
Optimizing the use of vilobelimab for the treatment of COVID-19Matthew W McCarthy
Expert Opinion on Biological Therapy|May 6, 2023
Interferon lambda as a potential treatment for COVID-19Matthew W McCarthy
Drugs in R&D|August 23, 2022
Novel Strategies for the Treatment of COVID-19Matthew W McCarthy
Expert Opinion on Pharmacotherapy|May 17, 2023
Metformin as a potential treatment for COVID-19Matthew W MCCarthy
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2022
Fluticasone propionate as a potential treatment for COVID-19Matthew W McCarthy
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Expert Opinion on Pharmacotherapy|March 17, 2023
Montelukast as a potential treatment for COVID-19Matthew W McCarthy
Drugs of Today (Barcelona, Spain : 1998)|February 27, 2023
Anakinra as a potential treatment for COVID-19Matthew W McCarthy
Expert Opinion on Drug Metabolism & Toxicology|March 3, 2025
Ceftobiprole medocaril for skin and skin-structure infectionsMatthew W McCarthy
Expert Opinion on Pharmacotherapy|February 23, 2024
Simnotrelvir as a potential treatment for COVID-19Matthew W McCarthy
Expert Opinion on Pharmacotherapy|September 21, 2024
The first five years of SARS-CoV-2: inpatient treatment updates and future directionsMatthew W McCarthy
Expert Opinion on Biological Therapy|July 8, 2023
Optimizing the use of vilobelimab for the treatment of COVID-19Matthew W McCarthy
Expert Opinion on Biological Therapy|May 6, 2023
Interferon lambda as a potential treatment for COVID-19Matthew W McCarthy
Drugs in R&D|August 23, 2022
Novel Strategies for the Treatment of COVID-19Matthew W McCarthy
Expert Opinion on Pharmacotherapy|May 17, 2023
Metformin as a potential treatment for COVID-19Matthew W MCCarthy
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2022
Fluticasone propionate as a potential treatment for COVID-19Matthew W McCarthy
Pageof 8